Mosaic gp140 + Adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mosaic gp140 + Adjuvant, covering 2025-01-07 to 2025-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults [Phase 1, Phase 2]